{
    "Trade/Device Name(s)": [
        "VITEK 2 AST-Gram Positive Linezolid",
        "VITEK 2 AST-GP Linezolid"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K212849",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032766"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "September 8, 2021",
    "Summary Letter Received Date": "September 9, 2021",
    "Submission Date": "September 3, 2021",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Linezolid"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [
        "Saline suspension"
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK 2 System",
        "VITEK 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Automated quantitative antimicrobial susceptibility testing",
        "Microdilution minimum inhibitory concentration (MIC)"
    ],
    "Methodologies": [
        "Automated susceptibility testing",
        "Microdilution MIC"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST-GP Linezolid antimicrobial susceptibility testing card for Gram positive organisms on VITEK 2 systems.",
    "Indications for Use Summary": "For in vitro quantitative antimicrobial susceptibility testing of Gram positive microorganisms using VITEK 2 or VITEK 2 Compact systems to determine susceptibility to linezolid, including Staphylococcus spp., Enterococcus spp., and Streptococcus agalactiae.",
    "fda_folder": "Microbiology"
}